1.
da Silva LRS, da Silva LRS, Costa YK dos S, da Rocha FHBP, de Sousa VFA, Pereira LM, et al. Analysis of the benefits of developing vaccines against leishmaniasis compared to the classic treatment. Editora [Internet]. 2024 Aug. 14 [cited 2025 Aug. 21];:640-55. Available from: https://sevenpubl.com.br/editora/article/view/5292